Company Filing History:
1 out of 23 
1 out of 330 
Years Active: 2001-2014
Title: Dietmar Schummer: Innovator in Pharmaceutical Composition
Introduction
Dietmar Schummer is a notable inventor based in Langen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at combating bacterial biofilms and treating diabetes mellitus. With a total of two patents to his name, Schummer's work reflects a commitment to advancing medical science.
Latest Patents
Schummer's latest patents include a pharmaceutical composition effective against biofilms. This invention introduces a compound known as Carolacton, which is designed for medical use to prevent biofilm formation by bacteria. Another significant patent is for Mumbaistatin, which details a process for its production and its application as a pharmaceutical. Mumbaistatin is derived from the microorganism HIL-008003 (DSM 11641) and acts as a glucose-6-phosphate translocase inhibitor, making it a potential treatment for diabetes mellitus.
Career Highlights
Throughout his career, Dietmar Schummer has worked with prominent organizations such as Helmholtz-Zentrum für Infektionsforschung GmbH and Aventis Pharma Deutschland GmbH. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Schummer has collaborated with esteemed colleagues, including Brigitte Kunze and Irene Wagner-Döbler. These partnerships have fostered an environment of innovation and have been instrumental in the advancement of his research.
Conclusion
Dietmar Schummer's contributions to pharmaceutical innovation, particularly in the areas of biofilm prevention and diabetes treatment, underscore his role as a significant inventor in the medical field. His work continues to impact the development of effective pharmaceutical solutions.